$44.63
2.445.78%
At Close: -
$44.67
0.040.09%
After Hours: 4:20 PM EDT
15 minutes delayed
Avidity Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Avidity Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-09 | $-0.65 | $-0.79 | 17.7 % |
Mar 2024 | 2024-05-09 | $-0.79 | $-0.78 | -1.28 % |
Dec 2023 | 2024-02-28 | $-0.79 | $-0.66 | -19.7 % |
Sep 2023 | 2023-11-08 | $-0.71 | $-0.77 | 7.79 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-09 | $2.05M | $2.64M | -22.5 % |
Mar 2024 | 2024-05-09 | $3.54M | $2.56M | 38.4 % |
Sep 2023 | 2023-11-08 | $2.82M | $1.84M | 53.1 % |
Jun 2023 | 2023-08-08 | $2.32M | $2.14M | 8.22 % |
Avidity Biosciences (RNA) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 9, 2024 for Q2.
The Actual EPS was $-0.65, which beat the estimate of $-0.79.
The Actual Revenue was $2M, which missed the estimate of $2.6M.
Browse earnings estimates, EPS, and revenue on all stocks.